BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC)

  Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.

  May 23, 2024

   · 

  3 min read
• Drug Development

  Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

  Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd., announced encouraging initial findings from an ongoing Phase 1 clinical trial.

  May 23, 2024

   · 

  9 min read
• Pharm Country

  Scientific Industries to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

  Scientific Industries, Inc. announced it will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.

  May 23, 2024

   · 

  2 min read
• Extendicare Announces Voting Results for its 2024 Annual Meeting of Shareholders

  Extendicare Inc. announced the results of matters voted on at its annual meeting of shareholders held on May 23, 2024.

  May 23, 2024

   · 

  4 min read
• Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024

  Oxurion NV, a biopharmaceutical company headquartered in Leuven, held its annual shareholders’ meeting on May 16, 2024.

  May 23, 2024

   · 

  1 min read
• Brainomix Showcases Growing Evidence for its Novel AI-Based Imaging Biomarkers in Lung Fibrosis

  Brainomix, a pioneer in artificial intelligence (AI) imaging solutions to enable precision medicine, announced a series of new studies that were presented this week at the American Thoracic Society (ATS) Conference in San Diego.

  May 23, 2024

   · 

  3 min read
• Lone Star Bio

  Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference

  Natera, Inc. today announced that members of Natera’s management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET).

  May 23, 2024

   · 

  1 min read
• Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences

  Inotiv, Inc. today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in the upcoming 21st Annual Craig Hallum Institutional Investor Conference and Jefferies Global Healthcare Conference.

  May 23, 2024

   · 

  3 min read
• Genetown

  NANOBIOTIX to Present at the Jefferies Global Healthcare Conference

  NANOBIOTIX announced today that Company management will participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference. Please see below for details of the event.

  May 23, 2024

   · 

  3 min read
• Biotech Beach

  Tandem Diabetes Care Announces Upcoming Conference Presentation - May 23, 2024

  Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:00am Eastern Time.

  May 23, 2024

   · 

  1 min read